Ondansetron Pch (Ondansetron)

Ondansetron is a selective 5‑HT3 receptor antagonist used to prevent and treat nausea and vomiting in several clinical settings.

• Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes.
• Radiation‑induced nausea and vomiting: helps control symptoms during and after radiotherapy.
• Post‑operative nausea and vomiting: decreases the incidence of nausea and vomiting after surgical procedures.
• Pregnancy‑related hyperemesis gravidarum (off‑label in some regions): may be used when conventional therapy fails.

• Ondansetron blocks the serotonin 5‑HT3 receptors located on vagal afferent nerves in the gastrointestinal tract and in the chemoreceptor trigger zone of the brain. By preventing serotonin from binding to these receptors, it interrupts the neural signaling pathway that initiates the vomiting reflex, thereby reducing nausea and vomiting.

Common Side Effects

• Headache: mild to moderate intensity.
• Constipation: occasional bowel movement difficulty.
• Diarrhoea: loose stools may occur.
• Fatigue: feeling of tiredness or reduced energy.
• Dizziness: transient light‑headedness.
• Injection site pain (if administered parenterally): mild discomfort at the injection site.

Serious or Rare Side Effects

• Cardiac arrhythmia: QT‑interval prolongation that can lead to serious rhythm disturbances.
• Severe allergic reaction: rash, itching, swelling, or anaphylaxis.
• Serotonin syndrome: rare but possible when combined with other serotonergic agents.
• Hepatic dysfunction: elevated liver enzymes indicating liver stress.
• Neuroleptic malignant-like syndrome: very rare, characterized by fever and muscle rigidity.
• Vision changes: blurred vision or visual disturbances.

Before prescribing Ondansetron, clinicians should assess patient history and comorbidities.

• Cardiac risk assessment: evaluate for prolonged QT interval or electrolyte abnormalities.
• Concomitant serotonergic drugs: avoid or monitor for serotonin syndrome.
• Hepatic impairment: adjust dose or monitor liver function tests.
• Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed.
• Pediatric use: dose must be individualized based on weight and age.
• Store at ambient temperature: keep below 25 °C, retain original packaging, and protect from moisture.

Ondansetron may interact with several medicines that affect cardiac rhythm or serotonin pathways.

Major Interactions (Avoid)

• Amiodarone: combined use can markedly prolong QT interval.
• Certain anti‑arrhythmics (e.g., sotalol, quinidine): increase risk of serious ventricular arrhythmias.
• Serotonergic agents (e.g., SSRIs, MAOIs, tramadol): heightened risk of serotonin syndrome.

Moderate Interactions (Monitor Closely)

• Antifungal azoles (e.g., ketoconazole, fluconazole): may increase ondansetron plasma levels.
• CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): modestly raise drug exposure.
• Digoxin: potential for altered serum concentrations.
• Oral contraceptives: may slightly reduce efficacy of hormonal contraception.
• Antacids: can affect absorption if taken simultaneously.